# Democratic People\'s Republic of Korea Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Democratic People\'s Republic of Korea HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Democratic People\'s Republic of Korea (PRK)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $8.8M
- Products: 24
- Buyer markets: 20
- Average CAGR: -1.7%
- Global sector size: $110.9B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $53.8B | $617.6K | $24.2B | -12.0% | 9 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $21.3B | $382.7K | $8.9B | +6.8% | 9 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $11.9B | $3.5M | $8.6B | +6.7% | 6 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $5.0B | $3.0K | $2.5B | -8.7% | 2 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $8.8K | $1.9B | +5.6% | 1 | +0.0% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $8.8K | $1.5B | -0.5% | 1 | +0.0% |
| HS 310221 - Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $1.2M | $1.3B | +11.1% | 1 | +0.3% |
| HS 290110 - Acyclic hydrocarbons: saturated | $613.2M | $12.5K | $1.1B | -43.8% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $1.2B | $811.2K | $1.1B | +18.6% | 1 | +0.3% |
| HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $54.1K | $996.7M | +14.5% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $9.4 | $990.0M | -30.4% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $895.5M | $72.8K | $958.6M | +12.2% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $53.9 | $798.7M | -24.7% | 1 | +0.0% |
| HS 280920 - Phosphoric acid and polyphosphoric acids | $417.4M | $5.1K | $714.9M | -19.9% | 1 | +0.0% |
| HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $1.6B | $14.3K | $713.0M | -8.2% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.5B | $2.0M | $624.0M | +2.1% | 1 | +0.7% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $936.8M | $25.5K | $580.1M | +43.8% | 1 | +0.0% |
| HS 290250 - Cyclic hydrocarbons: styrene | $1.2B | $48.9K | $527.4M | -41.2% | 1 | +0.0% |
| HS 294110 - Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | $485.4M | $34.3K | $508.6M | +30.4% | 1 | +0.0% |
| HS 350691 - Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $1.2B | $130.0 | $489.4M | -17.1% | 1 | +0.0% |
| HS 291521 - Acids: saturated acyclic monocarboxylic acids: acetic acid | $465.8M | $26.3K | $442.1M | +6.1% | 1 | +0.0% |
| HS 320890 - Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | $929.3M | $5.7K | $442.0M | +0.8% | 1 | +0.0% |
| HS 280300 - Carbon: carbon blacks and other forms of carbon n.e.s. | $512.9M | $19.3K | $417.6M | -3.3% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $387.7M | $53.0K | $406.6M | -7.3% | 1 | +0.2% |

## Best markets

- China (CHN): $15.2B calculated opportunity across 7 products.
- Slovenia (SVN): $10.1B calculated opportunity across 2 products.
- India (IND): $6.9B calculated opportunity across 9 products.
- Spain (ESP): $5.9B calculated opportunity across 2 products.
- Brazil (BRA): $5.1B calculated opportunity across 5 products.
- Poland (POL): $2.7B calculated opportunity across 3 products.
- Germany (DEU): $2.7B calculated opportunity across 2 products.
- Mexico (MEX): $2.6B calculated opportunity across 2 products.
- Russia (RUS): $1.6B calculated opportunity across 2 products.
- Indonesia (IDN): $1.1B calculated opportunity across 1 products.
- Canada (CAN): $1.0B calculated opportunity across 1 products.
- Thailand (THA): $1.0B calculated opportunity across 2 products.

## Growth stars

- HS 293339: +43.8% average CAGR, $580.1M calculated opportunity.
- HS 294110: +30.4% average CAGR, $508.6M calculated opportunity.
- HS 300439: +18.6% average CAGR, $1.1B calculated opportunity.
- HS 320611: +14.5% average CAGR, $996.7M calculated opportunity.
- HS 293499: +12.2% average CAGR, $958.6M calculated opportunity.
- HS 310221: +11.1% average CAGR, $1.3B calculated opportunity.
- HS 330499: +6.8% average CAGR, $8.9B calculated opportunity.
- HS 382499: +6.7% average CAGR, $8.6B calculated opportunity.
- HS 291521: +6.1% average CAGR, $442.1M calculated opportunity.
- HS 382319: +5.6% average CAGR, $1.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 9 buyer markets, $24.2B calculated opportunity.
- HS 330499: 9 buyer markets, $8.9B calculated opportunity.
- HS 382499: 6 buyer markets, $8.6B calculated opportunity.
- HS 382200: 2 buyer markets, $2.5B calculated opportunity.
- HS 382319: 1 buyer markets, $1.9B calculated opportunity.
- HS 284690: 1 buyer markets, $1.5B calculated opportunity.
- HS 310221: 1 buyer markets, $1.3B calculated opportunity.
- HS 290110: 1 buyer markets, $1.1B calculated opportunity.
- HS 300439: 1 buyer markets, $1.1B calculated opportunity.
- HS 320611: 1 buyer markets, $996.7M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.